Echelon Wealth Partners analyst Rob Goff maintained a Buy rating on CloudMD Software & Services (DOCRF) on August 24 and set a price target of C$1.70. The company’s shares closed last Thursday at $1.27, close to its 52-week high of $1.45.
Goff has an average return of 136.8% when recommending CloudMD Software & Services.
According to TipRanks.com, Goff is ranked #500 out of 6910 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CloudMD Software & Services with a $1.32 average price target, implying a -8.3% downside from current levels. In a report issued on August 31, Canaccord Genuity also maintained a Buy rating on the stock with a C$1.75 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $1.45 and a one-year low of $0.20. Currently, CloudMD Software & Services has an average volume of 411.6K.
Based on the recent corporate insider activity of 16 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of DOCRF in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Premier Health Group Inc. is a Canadian company. It is focused on health care approaches that combine human skill-based expertise with emerging technologies. The firm along with its subsidiary offers SAAS based health technology solutions including a cloud-based Electronic Medical Records (EMR) software, medical billing software and an online patient portal, Premier Health Group is also developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI).
